Modes of Action for Mucosal Vaccine Adjuvants-Reference-Cited by-同舟云学术

Modes of Action for Mucosal Vaccine Adjuvants

Published:2017-07 Issue:6 Volume:30 Page:463-470
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Aoshi Taiki¹

Affiliation:

1. Vaccine Dynamics Project, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Disease, Osaka University, Osaka, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2017.0026

Reference65 articles.

1. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function

2. Antigen processing and CD24 expression determine antigen presentation by splenic CD4+and CD8+dendritic cells

3. MPYS/STING-Mediated TNF-α, Not Type I IFN, Is Essential for the Mucosal Adjuvant Activity of (3′–5′)-Cyclic-Di-Guanosine-Monophosphate In Vivo

4. The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo

5. The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of plant-derived products as adjuvants for immune activation and vaccine development;Vaccine;2024-11

2. Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response;Journal of Controlled Release;2024-05

3. Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein;Vaccines;2024-04-23

4. Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization;Vaccines;2024-03-18

5. Innovative translational platforms for rapid developing clinical vaccines against COVID‐19 and other infectious disease;Biotechnology Journal;2024-02